Newly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis.

Newly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis.
🐶🐱🦠 #Dogs and #cats can carry #antibiotic-resistant #bacteria and potentially exchange them with people, highlighting the importance of a #OneHealth approach to #antimicrobial resistance.
#AMR #AntimicrobialResistance #Microbiology #Microsky via @sciencex.bsky.social
Our September issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #malaria #Aspergillus #hantavirus #tuberculosis #AMR #typhoid #mpox
🦠 Antimicrobial Resistance | A Global Health Security #PUBLICHEALTH2027
📅 July 19–20, 2027
📍 Prague, Czech Republic
From resistance data to public health action.
#AMR #Epidemiology #PublicHealth @publichealth.boston.gov @publichealthinst.bsky.social @publichealth.berkeley.edu @hsph.harvard.edu
Montpellier, on se retrouve à 15h chez Planetes Interdites puis au Mi Barrio pour le lancement de la tournée ! Avec un ex-libris exclusif disponible gratuitement sur place.
When I hear drug resistance, my first thought as a microbiologist is #AMR. But, that's not the only type of drug resistance out there.
Our researchers are looking into cancer drug resistance, and studying healthy cells response to chemotherapy.
New story written by my colleagues now live ⤵️
At #SASVEPM2026, ISID-Africa’s Dr Mohamed Sirdar contributed to capacity building on the early detection of transboundary animal diseases and presented research highlighting a critical gap in #AMR surveillance for animal health.
🔗 Read more: https://ow.ly/t7Qr50ZMqnP
Why Expertise Networks Matter in Respiratory Diseases
Acute respiratory infections drive healthcare visits & antibiotic use, yet diagnosis remains uncertain, contributing to #AMR. Ecraid connects respiratory experts across Europe - Want to advance respiratory research? Connect: eu1.hubs.ly/H0y9_k_0
Dr. Charlebois has co-founded a company, BioSciAI Inc., alongside Dr. Shamanth Shankarnarayan. BioSciAI is engineering AI-driven technologies to identify life-threatening pathogens in minutes, not days. Follow us on LinkedIn (lnkd.in/gZJ5u-5z) and check out our website (biosciai.ai)! #AMR #AI #Fungi
The Cheshire Cat #Cheshire #CheshireCat #AliceInWonderland #AliceMadnessReturns #AMR #Alice #Fanart
A new study found temocillin was non-inferior to carbapenems for targeted treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacterales. The findings support ongoing efforts to expand carbapenem-sparing strategies. #AMR
🌡️🦠 #Heat waves temporarily reduced antibiotic resistance #genes in #European #soils, but also disrupted #microbial communities and important #ecosystem functions.
#AMR #AntimicrobialResistance #Microbiology #ClimateChange #Microsky via @sciencex.bsky.social
AMR goes beyond science. Its legal & societal implications matter too.
At ARCANE, we want your perspectives.
Submit a talk or poster: arcane.sciencesconf.org
#ARCANE2026 #CallForAbstracts #AntimicrobialResistance #AMR #HealthcareNetworks #InfectiousDiseaseModelling #PublicHealth #Epidemiology
In this feature article, #MicheleSolis highlights how as antifungal resistance becomes more common, researchers, clinicians and pharmacists are looking for innovative ways to stay ahead
Not all drinking water sources face the same antibiotic resistance risk. A basin-scale study of 13 sources in Poyang Lake found higher risks in river-type sources than reservoirs, with summer showing greater ARG abundance.
#AMR #WaterQuality #AntibioticResistance
🚨 More than $50,000,000 in insider buys from one #AMR director over the past year...
Including $12 million in the last three weeks alone 🌶️
Insider Buy Scan ⬇️
trendspider.cc/InsiderBuyScan
Many National Action Plans on AMR lack measurable targets, weakening accountability and monitoring.
A new @frontiersin.bsky.social paper from GSL's AMR Policy Accelerator makes the case for clear, measurable targets in NAPs.